These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

674 related items for PubMed ID: 17309456

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Results of a randomized, double-blind, vehicle-controlled efficacy trial of pimecrolimus cream 1% for the treatment of moderate to severe facial seborrheic dermatitis.
    Warshaw EM, Wohlhuter RJ, Liu A, Zeller SA, Wenner RA, Bowers S, Schultz JC, Katz HI, McCormick CL, Parneix-Spake A.
    J Am Acad Dermatol; 2007 Aug; 57(2):257-64. PubMed ID: 17188780
    [Abstract] [Full Text] [Related]

  • 3. An investigator-blind, randomized, 4-week, parallel-group, multicenter pilot study to compare the safety and efficacy of a nonsteroidal cream (Promiseb Topical Cream) and desonide cream 0.05% in the twice-daily treatment of mild to moderate seborrheic dermatitis of the face.
    Elewski B.
    Clin Dermatol; 2009 Aug; 27(6 Suppl):S48-53. PubMed ID: 19878781
    [Abstract] [Full Text] [Related]

  • 4. An open, randomized, prospective, comparative study of topical pimecrolimus 1% cream and topical ketoconazole 2% cream in the treatment of seborrheic dermatitis.
    Koc E, Arca E, Kose O, Akar A.
    J Dermatolog Treat; 2009 Aug; 20(1):4-9. PubMed ID: 18677657
    [Abstract] [Full Text] [Related]

  • 5. Pimecrolimus 1% cream, methylprednisolone aceponate 0.1% cream and metronidazole 0.75% gel in the treatment of seborrhoeic dermatitis: a randomized clinical study.
    Cicek D, Kandi B, Bakar S, Turgut D.
    J Dermatolog Treat; 2009 Aug; 20(6):344-9. PubMed ID: 19954391
    [Abstract] [Full Text] [Related]

  • 6. A comparison of 15% azelaic acid gel and 0.75% metronidazole gel in the topical treatment of papulopustular rosacea: results of a randomized trial.
    Elewski BE, Fleischer AB, Pariser DM.
    Arch Dermatol; 2003 Nov; 139(11):1444-50. PubMed ID: 14623704
    [Abstract] [Full Text] [Related]

  • 7. A novel foam formulation of ketoconazole 2% for the treatment of seborrheic dermatitis on multiple body regions.
    Elewski BE, Abramovits W, Kempers S, Schlessinger J, Rosen T, Gupta AK, Abraham S, Rowell R.
    J Drugs Dermatol; 2007 Oct; 6(10):1001-8. PubMed ID: 17966177
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of a new once-daily topical ketoconazole 2% gel in the treatment of seborrheic dermatitis: a phase III trial.
    Elewski B, Ling MR, Phillips TJ.
    J Drugs Dermatol; 2006 Oct; 5(7):646-50. PubMed ID: 16865870
    [Abstract] [Full Text] [Related]

  • 9. Is metronidazole 0.75% gel effective in the treatment of seborrhoeic dermatitis? A double-blind, placebo controlled study.
    Ozcan H, Seyhan M, Yologlu S.
    Eur J Dermatol; 2007 Oct; 17(4):313-6. PubMed ID: 17540638
    [Abstract] [Full Text] [Related]

  • 10. Comparative study of 2% ketoconazole cream and 1% hydrocortisone cream in the treatment of infantile seborrheic dermatitis.
    Wannanukul S, Chiabunkana J.
    J Med Assoc Thai; 2004 Sep; 87 Suppl 2():S68-71. PubMed ID: 16083165
    [Abstract] [Full Text] [Related]

  • 11. A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis.
    Ling M, Gottlieb A, Pariser D, Caro I, Stewart D, Scott G, Abrams K.
    J Dermatolog Treat; 2005 Aug; 16(3):142-8. PubMed ID: 16096179
    [Abstract] [Full Text] [Related]

  • 12. A randomized controlled trial of pimecrolimus cream 1% in adolescents and adults with head and neck atopic dermatitis and intolerant of, or dependent on, topical corticosteroids.
    Murrell DF, Calvieri S, Ortonne JP, Ho VC, Weise-Riccardi S, Barbier N, Paul CF.
    Br J Dermatol; 2007 Nov; 157(5):954-9. PubMed ID: 17935515
    [Abstract] [Full Text] [Related]

  • 13. Randomized, open-labeled, non-inferiority study between ciclopiroxolamine 1% cream and ketoconazole 2% foaming gel in mild to moderate facial seborrheic dermatitis.
    Chosidow O, Maurette C, Dupuy P.
    Dermatology; 2003 Nov; 206(3):233-40. PubMed ID: 12673081
    [Abstract] [Full Text] [Related]

  • 14. Effects of tazarotene 0.1 % cream in the treatment of facial acne vulgaris: pooled results from two multicenter, double-blind, randomized, vehicle-controlled, parallel-group trials.
    Shalita AR, Berson DS, Thiboutot DM, Leyden JJ, Parizadeh D, Sefton J, Walker PS, Gibson JR, Tazarotene Cream in Acne Clinical Study Investigator Group.
    Clin Ther; 2004 Nov; 26(11):1865-73. PubMed ID: 15639698
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of topical 4% Quassia amara gel in facial seborrheic dermatitis:a randomized, double-blind, comparative study.
    Diehl C, Ferrari A.
    J Drugs Dermatol; 2013 Mar; 12(3):312-5. PubMed ID: 23545914
    [Abstract] [Full Text] [Related]

  • 16. Once-daily topical metronidazole cream formulations in the treatment of the papules and pustules of rosacea.
    Dahl MV, Jarratt M, Kaplan D, Tuley MR, Baker MD.
    J Am Acad Dermatol; 2001 Nov; 45(5):723-30. PubMed ID: 11606923
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Single-blind, randomized controlled trial evaluating the treatment of facial seborrheic dermatitis with hydrocortisone 1% ointment compared with tacrolimus 0.1% ointment in adults.
    Papp KA, Papp A, Dahmer B, Clark CS.
    J Am Acad Dermatol; 2012 Jul; 67(1):e11-5. PubMed ID: 22101215
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.